Modular Medical, Inc. (MODD)
| Market Cap | 16.16M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -14.88M |
| Shares Out | 10.93M |
| EPS (ttm) | -1.48 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,059 |
| Open | 1.50 |
| Previous Close | 1.60 |
| Day's Range | 1.44 - 1.50 |
| 52-Week Range | 1.45 - 5.43 |
| Beta | -3.15 |
| Analysts | Buy |
| Price Target | 7.48 (+406.09%) |
| Earnings Date | Feb 13, 2023 |
About MODD
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California. [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for MODD stock is "Buy." The 12-month stock price forecast is $7.48, which is an increase of 406.09% from the latest price.
News
Modular Medical Provides Update on FDA Submission Strategy
SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the ...
Modular Medical Announces Product Testing Update
SAN DIEGO, CA / ACCESSWIRE / November 28, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch th...
Modular Medical Announces Participation at Upcoming Investor Conferences
SAN DIEGO, CA / ACCESSWIRE / November 23, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch th...
Modular Medical Provides Product Update
SAN DIEGO, CA / ACCESSWIRE / October 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the n...
Dr. Anne Peters Joins the Modular Medical Advisory Board
Dr. Peters, a prominent diabetes clinician and clinical researcher, is a leading voice in the fight to bring diabetes technology and therapeutics to under-resourced communities SAN DIEGO, CA / ACCESSW...
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing SAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Med...
Modular Medical to Present at LD Micro Invitational XII Investor Conference
SAN DIEGO, CA / ACCESSWIRE / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next...
Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022
SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of e...
Modular Medical Announces $8 Million Registered Direct Offering
SAN DIEGO, CA / ACCESSWIRE / May 3, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), today announced that it has entered into a securities purchase agreement with insti...
Modular Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference
SAN DIEGO, CA / ACCESSWIRE / March 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the nex...
Modular Medical Appoints James "Jeb" Besser as Chief Executive Officer
Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MODD1 insulin pump to FD...
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market
SAN DIEGO, CA / ACCESSWIRE / February 10, 2022 / Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delive...
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
SAN DIEGO, CA / ACCESSWIRE / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery...
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
SAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity t...